Balance Sheet

Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Axogen (AXGN) Other financing activities (2017 - 2026)

Axogen has reported Other financing activities over the past 7 years, most recently at $792000.0 for Q1 2026.

For Q1 2026, Other financing activities changed N/A year-over-year to $792000.0; the TTM value through Mar 2026 reached $792000.0, changed N/A, while the annual FY2020 figure was $642000.0, N/A changed from the prior year.
Other financing activities for Q1 2026 was $792000.0 at Axogen, up from $292000.0 in the prior quarter.
Over five years, Other financing activities peaked at $792000.0 in Q1 2026 and troughed at $792000.0 in Q1 2026.